Search

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
GET IN TOUCH
Our Company Recognitions

Recognitions

Awards

View all Awards
CEO of the Year 2022

Mr. Manni Kantipudi Recognised as the ‘CEO of the Year 2022’ at CPHI Frankfurt, Germany

November 2022
Silver rating from EcoVadis

Aragen has received Silver rating in recognition of our sustainability initiatives from EcoVadis for the second year in a row.

October 2022
Top Organizations with Best Workplace Practices

Aragen has received the “Top Organizations with Best Workplace Practices” award from the Asia Pacific HRM Congress.

September 2022
View all Awards

Testimonials

View all Testimonials
Chris Nasveschuk Senior Vice President, Chemistry
C4 Therapeutics Inc.
“Aragen’s expertise across chemistry and biology has helped C4T further research in targeted protein degradation. With close collaboration and trust between our teams, we enjoy working with Aragen to further our shared commitment to advancing scientific research to develop innovative medicines for patients.”
Dr. Kathleen Shelton Vice President and Chief Technology Officer
FMC Corporation
“Aragen has been a valued collaborator of FMC for several years. This partnership extends across multiple disciplines in research and development and we appreciate our strong working relationship.”
Rajat Sood Managing Director
Goldman Sachs Asset Management
“Aragen is well positioned to benefit from the secular trend of increased outsourcing by the life sciences industry. With a clear value creation plan in place, we look forward to closely working with the management and shareholders of Aragen. Goldman Sachs is actively seeking to invest and foster leading, national champions of India who are building companies of a global scale.”
View all Testimonials

Publications

View all Publications
2019

Chemistry

Galeterone and the Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-resistant Prostate Cancer Preclinical Models in vitro and in vivo

Andrew K. Kwegyir-Afful, Senthilmurugan Ramalingam, Vidya P. Ramamurthy, Puranik Purushottamachar, Francis N. Murigi, Tadas S. Vasaitis, Weiliang Huang, Maureen A. Kane, Yuji Zhang, Nicholas Ambulos, Sudhir Tiwari, Pratima Srivastava, Ivo P. Nnane, Arif Hussain, Yun Qiu, David J. Weber, Vincent C. O. Njar
(Basel). 2019 Nov; 11(11), 1637

Chemistry

Chemistry

Oxidative Degradation Profile Studies of Tavaborole by a Validated Stability Indicating RP-UPLC method: Isolation and Characterization of Novel Degradant using 2D-NMR and HRMS

Umamaheshwar Puppala , Vishnu Murthy Marisetti, Koduri S V Srinivas, K Venkateshwara Reddy, Muralidharan Kaliyaperumal, Raju Doddipalla
Biomedical Chromatography | Language: English, Database: CAplus and MEDLINE

Chemistry

Biology

Mass Spectrometry as a Workhorse for Preclinical Drug Discovery: Special Emphasis on Drug Metabolism and Pharmacokinetics

Vijayabhaskar Veeravalli, Lakshmi Mohan Vamsi Madgula, Pratima Srivastava
10.5772/intechopen.88385. In book: Mass Spectrometry – Future Perceptions and Applications

Download

Biology

View all Publications